It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
This cross-sectional study aimed to build a deep learning model for detecting neovascular age-related macular degeneration (AMD) and to distinguish retinal angiomatous proliferation (RAP) from polypoidal choroidal vasculopathy (PCV) using a convolutional neural network (CNN). Patients from a single tertiary center were enrolled from January 2014 to January 2020. Spectral-domain optical coherence tomography (SD-OCT) images of patients with RAP or PCV and a control group were analyzed with a deep CNN. Sensitivity, specificity, accuracy, and area under the receiver operating characteristic curve (AUROC) were used to evaluate the model’s ability to distinguish RAP from PCV. The performances of the new model, the VGG-16, Resnet-50, Inception, and eight ophthalmologists were compared. A total of 3951 SD-OCT images from 314 participants (229 AMD, 85 normal controls) were analyzed. In distinguishing the PCV and RAP cases, the proposed model showed an accuracy, sensitivity, and specificity of 89.1%, 89.4%, and 88.8%, respectively, with an AUROC of 95.3% (95% CI 0.727–0.852). The proposed model showed better diagnostic performance than VGG-16, Resnet-50, and Inception-V3 and comparable performance with the eight ophthalmologists. The novel model performed well when distinguishing between PCV and RAP. Thus, automated deep learning systems may support ophthalmologists in distinguishing RAP from PCV.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Hangil Eye Hospital, Department of Ophthalmology, Incheon, South Korea; Catholic Kwandong University College of Medicine, Department of Ophthalmology, Incheon, South Korea
2 Sungkyunkwan University, Department of Applied Artificial Intelligence, Seoul, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); RAON DATA, Seoul, South Korea (GRID:grid.264381.a)
3 Sungkyunkwan University, Department of Applied Artificial Intelligence, Seoul, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X)
4 Kangwon National University School of Medicine, Department of Medicine, Kangwon National University Hospital, Chuncheon, South Korea (GRID:grid.412010.6) (ISNI:0000 0001 0707 9039)
5 Seoul Plus Eye Clinic, Seoul, South Korea (GRID:grid.412010.6)
6 Kong Eye Center, Seoul, South Korea (GRID:grid.412010.6)
7 Hangil Eye Hospital, Department of Ophthalmology, Incheon, South Korea (GRID:grid.412010.6)
8 Seoul National University Bundang Hospital, Department of Ophthalmology, Seongnam, South Korea (GRID:grid.412480.b) (ISNI:0000 0004 0647 3378)